Chronic Fatigue Syndrome study: LingZhi capsule
Official title RCT of Efficacy and Safety of CP003 on CFS/ME or Post COVID-19 Fatigue
ClinicalTrials.gov ID: NCT06739720
What this study is testing
What is LingZhi capsule?
LingZhi capsule is an investigational medicine, taken by mouth once daily, being studied as a potential treatment for chronic fatigue syndrome (cfs).
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study checks if the supplement reduces fatigue and is safe to use. It also looks at how it affects the body's immune system and inflammation.
- Who it's for
- People living with chronic fatigue syndrome or fatigue that started after having COVID-19.
- What's involved
- Participants take 5 capsules once a day for 6 weeks. They visit the clinic twice for blood tests and fill out questionnaires about their energy levels and quality of life.
- Time commitment
- The study lasts 6 weeks and requires two clinic visits for blood tests.
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 60
You may be able to join if
- Meet the Fukuda diagnostic definition of CFS/ME or have persisting fatigue after the infection of SARS-CoV-2
- Are able to complete a 6-week course of intervention;
- Able to complete the online validated fatigue surveys.
You likely can't join if
- Have participated in any type of complements or herbal medicine within the past six months;
- Have serious medical conditions that might limit their participation in this intervention;
- Diagnosed with acute inflammation;
- Are pregnant or are planning a pregnancy in the next 3 months.
The study team makes the final eligibility decision.
Where it is enrolling
- Hong Kong, Hong Kong
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Hong Kong, Hong Kong. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.